Publications

1. D'Haene N, Sauvage S, Maris C, Adanja I, Mercier ML, Decaestecker C, Baum L, Salmon I. Correction: VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1- and Galectin-3-Induced Angiogenesis.. PloS one, 2023.
2. McMorran BJ, Miceli MC, Baum LG. Lectin-binding characterizes the healthy human skeletal muscle glycophenotype and identifies disease-specific changes in dystrophic muscle.. Glycobiology, 2017.
3. Schaefer K, Webb NE, Pang M, Hernandez-Davies JE, Lee KP, Gonzalez P, Douglass MV, Lee B, Baum LG. Galectin-9 binds to O-glycans on protein disulfide isomerase.. Glycobiology, 2017.
4. Baum LG, Cobb BA. The direct and indirect effects of glycans on immune function.. Glycobiology, 2017.
5. Baum LG, Haltiwanger RS. Why we love glycobiology.. Glycobiology, 2016.
6. McMorran BJ, McCarthy FE, Gibbs EM, Pang M, Marshall JL, Nairn AV, Moremen KW, Crosbie-Watson RH, Baum LG. Differentiation-related glycan epitopes identify discrete domains of the muscle glycocalyx.. Glycobiology, 2016.
7. Thiemann S, Baum LG. Galectins and Immune Responses-Just How Do They Do Those Things They Do?. Annual review of immunology, 2016.
8. Stone JA, Nicola AV, Baum LG, Aguilar HC. Multiple Novel Functions of Henipavirus O-glycans: The First O-glycan Functions Identified in the Paramyxovirus Family.. PLoS pathogens, 2016.
9. Baum LG. Sweet beginning for cancer stem cells.. Proceedings of the National Academy of Sciences of the United States of America, 2016.
10. Thiemann S, Man JH, Chang MH, Lee B, Baum LG. Galectin-1 regulates tissue exit of specific dendritic cell populations.. The Journal of biological chemistry, 2015.
11. Thiemann S, Man JH, Baum LG. Assessing the roles of galectins in regulating dendritic cell migration through extracellular matrix and across lymphatic endothelial cells.. Methods in molecular biology (Clifton, N.J.), 2015.
12. Garner OB, Yun T, Pernet O, Aguilar HC, Park A, Bowden TA, Freiberg AN, Lee B, Baum LG. Timing of galectin-1 exposure differentially modulates Nipah virus entry and syncytium formation in endothelial cells.. Journal of virology, 2014.
13. Baum LG, Garner OB, Schaefer K, Lee B. Microbe-Host Interactions are Positively and Negatively Regulated by Galectin-Glycan Interactions.. Frontiers in immunology, 2014.
14. D'Haene N, Sauvage S, Maris C, Adanja I, Le Mercier M, Decaestecker C, Baum L, Salmon I. VEGFR1 and VEGFR2 involvement in extracellular galectin-1- and galectin-3-induced angiogenesis.. PloS one, 2013.
15. Baum LG, Braun J. Introduction to special issue: Sugars, bugs and us.. Glycobiology, 2013.
16. Marshall JL, Kwok Y, McMorran BJ, Baum LG, Crosbie-Watson RH. The potential of sarcospan in adhesion complex replacement therapeutics for the treatment of muscular dystrophy.. The FEBS journal, 2013.
17. Clark MC, Pang M, Hsu DK, Liu FT, de Vos S, Gascoyne RD, Said J, Baum LG. Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death.. Blood, 2012.
18. Cabrera PV, Pang M, Marshall JL, Kung R, Nelson SF, Stalnaker SH, Wells L, Crosbie-Watson RH, Baum LG. High throughput screening for compounds that alter muscle cell glycosylation identifies new role for N-glycans in regulating sarcolemmal protein abundance and laminin binding.. The Journal of biological chemistry, 2012.
19. Clark MC, Baum LG. T cells modulate glycans on CD43 and CD45 during development and activation, signal regulation, and survival.. Annals of the New York Academy of Sciences, 2012.
20. Baum LG. Burn control, an adipocyte-specific function for galectin-12.. Proceedings of the National Academy of Sciences of the United States of America, 2011.
21. Miller MC, Ribeiro JP, Roldós V, Martín-Santamaría S, Cañada FJ, Nesmelova IA, André S, Pang M, Klyosov AA, Baum LG, Jiménez-Barbero J, Gabius HJ, Mayo KH. Structural aspects of binding of α-linked digalactosides to human galectin-1.. Glycobiology, 2011.
22. Bi S, Hong PW, Lee B, Baum LG. Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entry.. Proceedings of the National Academy of Sciences of the United States of America, 2011.
23. Earl LA, Bi S, Baum LG. Galectin multimerization and lattice formation are regulated by linker region structure.. Glycobiology, 2010.
24. Thiemann S, Baum LG. The road less traveled: regulation of leukocyte migration across vascular and lymphatic endothelium by galectins.. Journal of clinical immunology, 2010.
25. Garner OB, Aguilar HC, Fulcher JA, Levroney EL, Harrison R, Wright L, Robinson LR, Aspericueta V, Panico M, Haslam SM, Morris HR, Dell A, Lee B, Baum LG. Endothelial galectin-1 binds to specific glycans on nipah virus fusion protein and inhibits maturation, mobility, and function to block syncytia formation.. PLoS pathogens, 2010.
26. Nesmelova IV, Ermakova E, Daragan VA, Pang M, Menéndez M, Lagartera L, Solís D, Baum LG, Mayo KH. Lactose binding to galectin-1 modulates structural dynamics, increases conformational entropy, and occurs with apparent negative cooperativity.. Journal of molecular biology, 2010.
27. Earl LA, Bi S, Baum LG. N- and O-glycans modulate galectin-1 binding, CD45 signaling, and T cell death.. The Journal of biological chemistry, 2009.
28. Bi S, Baum LG. Sialic acids in T cell development and function.. Biochimica et biophysica acta, 2009.
29. Fulcher JA, Chang MH, Wang S, Almazan T, Hashimi ST, Eriksson AU, Wen X, Pang M, Baum LG, Singh RR, Lee B. Galectin-1 co-clusters CD43/CD45 on dendritic cells and induces cell activation and migration through Syk and protein kinase C signaling.. The Journal of biological chemistry, 2009.
30. Baum LG, Crocker PR. Glycoimmunology: ignore at your peril!. Immunological reviews, 2009.
31. Pang M, He J, Johnson P, Baum LG. CD45-mediated fodrin cleavage during galectin-1 T cell death promotes phagocytic clearance of dying cells.. Journal of immunology (Baltimore, Md. : 1950), 2009.
32. Perone MJ, Bertera S, Shufesky WJ, Divito SJ, Montecalvo A, Mathers AR, Larregina AT, Pang M, Seth N, Wucherpfennig KW, Trucco M, Baum LG, Morelli AE. Suppression of autoimmune diabetes by soluble galectin-1.. Journal of immunology (Baltimore, Md. : 1950), 2009.
33. Garner OB, Baum LG. Galectin-glycan lattices regulate cell-surface glycoprotein organization and signalling.. Biochemical Society transactions, 2008.
34. Nesmelova IV, Pang M, Baum LG, Mayo KH. 1H, 13C, and 15N backbone and side-chain chemical shift assignments for the 29 kDa human galectin-1 protein dimer.. Biomolecular NMR assignments, 2008.
35. Tenorio AR, Martinson J, Pollard D, Baum L, Landay A. The relationship of T-regulatory cell subsets to disease stage, immune activation, and pathogen-specific immunity in HIV infection.. Journal of acquired immune deficiency syndromes (1999), 2008.
36. Varki AP, Baum LG, Bellis SL, Cummings RD, Esko JD, Hart GW, Linhardt RJ, Lowe JB, McEver RP, Srivastava A, Sarkar R. Working group report: the roles of glycans in hemostasis, inflammation and vascular biology.. Glycobiology, 2008.
37. Okumura CY, Baum LG, Johnson PJ. Galectin-1 on cervical epithelial cells is a receptor for the sexually transmitted human parasite Trichomonas vaginalis.. Cellular microbiology, 2008.
38. Liu SD, Whiting CC, Tomassian T, Pang M, Bissel SJ, Baum LG, Mossine VV, Poirier F, Huflejt ME, Miceli MC. Endogenous galectin-1 enforces class I-restricted TCR functional fate decisions in thymocytes.. Blood, 2008.
39. Bi S, Earl LA, Jacobs L, Baum LG. Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways.. The Journal of biological chemistry, 2008.
40. Belitsky JM, Nelson A, Hernandez JD, Baum LG, Stoddart JF. Multivalent interactions between lectins and supramolecular complexes: Galectin-1 and self-assembled pseudopolyrotaxanes.. Chemistry & biology, 2007.
41. Hernandez JD, Klein J, Van Dyken SJ, Marth JD, Baum LG. T-cell activation results in microheterogeneous changes in glycosylation of CD45.. International immunology, 2007.
42. Valenzuela HF, Pace KE, Cabrera PV, White R, Porvari K, Kaija H, Vihko P, Baum LG. O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1.. Cancer research, 2007.
43. Thijssen VL, Poirier F, Baum LG, Griffioen AW. Galectins in the tumor endothelium: opportunities for combined cancer therapy.. Blood, 2007.
44. Toscano MA, Bianco GA, Ilarregui JM, Croci DO, Correale J, Hernandez JD, Zwirner NW, Poirier F, Riley EM, Baum LG, Rabinovich GA. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death.. Nature immunology, 2007.
45. Behbahani H, Walther-Jallow L, Klareskog E, Baum L, French AL, Patterson BK, Garcia P, Spetz AL, Landay A, Andersson J. Proinflammatory and type 1 cytokine expression in cervical mucosa during HIV-1 and human papillomavirus infection.. Journal of acquired immune deficiency syndromes (1999), 2007.
46. Cabrera PV, Baum LG. The emerging field of glycoimmunology: highlights from the Society for Glycobiology meeting, 2006.. Expert review of clinical immunology, 2007.
47. Thijssen VL, Postel R, Brandwijk RJ, Dings RP, Nesmelova I, Satijn S, Verhofstad N, Nakabeppu Y, Baum LG, Bakkers J, Mayo KH, Poirier F, Griffioen AW. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy.. Proceedings of the National Academy of Sciences of the United States of America, 2006.
48. Perone MJ, Bertera S, Tawadrous ZS, Shufesky WJ, Piganelli JD, Baum LG, Trucco M, Morelli AE. Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice.. Journal of immunology (Baltimore, Md. : 1950), 2006.
49. Hernandez JD, Nguyen JT, He J, Wang W, Ardman B, Green JM, Fukuda M, Baum LG. Galectin-1 binds different CD43 glycoforms to cluster CD43 and regulate T cell death.. Journal of immunology (Baltimore, Md. : 1950), 2006.
50. Kohatsu L, Hsu DK, Jegalian AG, Liu FT, Baum LG. Galectin-3 induces death of Candida species expressing specific beta-1,2-linked mannans.. Journal of immunology (Baltimore, Md. : 1950), 2006.
51. Fulcher JA, Hashimi ST, Levroney EL, Pang M, Gurney KB, Baum LG, Lee B. Galectin-1-matured human monocyte-derived dendritic cells have enhanced migration through extracellular matrix.. Journal of immunology (Baltimore, Md. : 1950), 2006.
52. Cabrera PV, Amano M, Mitoma J, Chan J, Said J, Fukuda M, Baum LG. Haploinsufficiency of C2GnT-I glycosyltransferase renders T lymphoma cells resistant to cell death.. Blood, 2006.
53. Perone MJ, Larregina AT, Shufesky WJ, Papworth GD, Sullivan ML, Zahorchak AF, Stolz DB, Baum LG, Watkins SC, Thomson AW, Morelli AE. Transgenic galectin-1 induces maturation of dendritic cells that elicit contrasting responses in naive and activated T cells.. Journal of immunology (Baltimore, Md. : 1950), 2006.
54. Baum LG. Women editors: change comes from focused action.. Nature, 2006.
55. He J, Baum LG. Endothelial cell expression of galectin-1 induced by prostate cancer cells inhibits T-cell transendothelial migration.. Laboratory investigation; a journal of technical methods and pathology, 2006.
56. Aguilar HC, Matreyek KA, Filone CM, Hashimi ST, Levroney EL, Negrete OA, Bertolotti-Ciarlet A, Choi DY, McHardy I, Fulcher JA, Su SV, Wolf MC, Kohatsu L, Baum LG, Lee B. N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry.. Journal of virology, 2006.
57. Stillman BN, Hsu DK, Pang M, Brewer CF, Johnson P, Liu FT, Baum LG. Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death.. Journal of immunology (Baltimore, Md. : 1950), 2006.
58. He J, Baum LG. Galectin interactions with extracellular matrix and effects on cellular function.. Methods in enzymology, 2006.
59. Levroney EL, Aguilar HC, Fulcher JA, Kohatsu L, Pace KE, Pang M, Gurney KB, Baum LG, Lee B. Novel innate immune functions for galectin-1: galectin-1 inhibits cell fusion by Nipah virus envelope glycoproteins and augments dendritic cell secretion of proinflammatory cytokines.. Journal of immunology (Baltimore, Md. : 1950), 2005.
60. Stillman BN, Mischel PS, Baum LG. New roles for galectins in brain tumors--from prognostic markers to therapeutic targets.. Brain pathology (Zurich, Switzerland), 2005.
61. Nelson A, Belitsky JM, Vidal S, Joiner CS, Baum LG, Stoddart JF. A self-assembled multivalent pseudopolyrotaxane for binding galectin-1.. Journal of the American Chemical Society, 2004.
62. Hoyer KK, Pang M, Gui D, Shintaku IP, Kuwabara I, Liu FT, Said JW, Baum LG, Teitell MA. An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas.. The American journal of pathology, 2004.
63. Lee JK, Baum LG, Moremen K, Pierce M. The X-lectins: a new family with homology to the Xenopus laevis oocyte lectin XL-35.. Glycoconjugate journal, 2004.
64. Baum LG, Blackall DP, Arias-Magallano S, Nanigian D, Uh SY, Browne JM, Hoffmann D, Emmanouilides CE, Territo MC, Baldwin GC. Amelioration of graft versus host disease by galectin-1.. Clinical immunology (Orlando, Fla.), 2003.
65. He J, Baum LG. Presentation of galectin-1 by extracellular matrix triggers T cell death.. The Journal of biological chemistry, 2003.
66. Lantéri M, Giordanengo V, Hiraoka N, Fuzibet JG, Auberger P, Fukuda M, Baum LG, Lefebvre JC. Altered T cell surface glycosylation in HIV-1 infection results in increased susceptibility to galectin-1-induced cell death.. Glycobiology, 2003.
67. Roberts AA, Amano M, Felten C, Galvan M, Sulur G, Pinter-Brown L, Dobbeling U, Burg G, Said J, Baum LG. Galectin-1-mediated apoptosis in mycosis fungoides: the roles of CD7 and cell surface glycosylation.. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2003.
68. Pace KE, Hahn HP, Baum LG. Preparation of recombinant human galectin-1 and use in T-cell death assays.. Methods in enzymology, 2003.
69. Amano M, Galvan M, He J, Baum LG. The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death.. The Journal of biological chemistry, 2002.
70. Hernandez JD, Baum LG. Ah, sweet mystery of death! Galectins and control of cell fate.. Glycobiology, 2002.
71. Brewer CF, Miceli MC, Baum LG. Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions.. Current opinion in structural biology, 2002.
72. Onami TM, Harrington LE, Williams MA, Galvan M, Larsen CP, Pearson TC, Manjunath N, Baum LG, Pearce BD, Ahmed R. Dynamic regulation of T cell immunity by CD43.. Journal of immunology (Baltimore, Md. : 1950), 2002.
73. Rabinovich GA, Baum LG, Tinari N, Paganelli R, Natoli C, Liu FT, Iacobelli S. Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?. Trends in immunology, 2002.
74. Pace KE, Lebestky T, Hummel T, Arnoux P, Kwan K, Baum LG. Characterization of a novel Drosophila melanogaster galectin. Expression in developing immune, neural, and muscle tissues.. The Journal of biological chemistry, 2002.
75. Baum LG. Developing a taste for sweets.. Immunity, 2002.
76. Pace KE, Baum LG. Insect galectins: roles in immunity and development.. Glycoconjugate journal, 2002.